Literature DB >> 26936668

Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.

Kathleen N Ly1, Elizabeth M Hughes1, Ruth B Jiles1, Scott D Holmberg1.   

Abstract

In the United States, hepatitis C virus (HCV)-associated mortality is increasing. From 2003-2013, the number of deaths associated with HCV has now surpassed 60 other nationally notifiable infectious conditions combined. The increasing HCV-associated mortality trend underscores the urgency in finding, evaluating, and treating HCV-infected persons. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  causes of death; death certificates; hepatitis C; mortality trends

Mesh：

Year:  2016        PMID： 26936668     DOI： 10.1093/cid/ciw111

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  149 in total

1.  Hepatitis C-Related Mortality Among American Indian/Alaska Native Persons in the Northwestern United States, 2006-2012.

Authors:  Sarah M Hatcher; Sujata Joshi; Byron F Robinson; Thomas Weiser
Journal:  Public Health Rep       Date:  2019-11-25       Impact factor: 2.792

Review 2.  Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.

Authors:  Megan G Hofmeister; Elizabeth M Rosenthal; Laurie K Barker; Eli S Rosenberg; Meredith A Barranco; Eric W Hall; Brian R Edlin; Jonathan Mermin; John W Ward; A Blythe Ryerson
Journal:  Hepatology       Date:  2018-11-06       Impact factor: 17.425

3.  Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City.

Authors:  Kelly Quinn; Chunki Fong; Honoria Guarino; Pedro Mateu-Gelabert
Journal:  Drug Alcohol Depend       Date:  2018-11-28       Impact factor: 4.492

4.  Monitoring the hepatitis C care cascade using administrative claims data.

Authors:  Cheryl Isenhour; Susan Hariri; Claudia Vellozzi
Journal:  Am J Manag Care       Date:  2018-05       Impact factor: 2.229

5.  Cigarette Smoking in Persons Living with Hepatitis C: The National Health and Nutrition Examination Survey (NHANES), 1999-2014.

Authors:  Ryung S Kim; Andrea H Weinberger; Geetanjali Chander; Mark S Sulkowski; Brianna Norton; Jonathan Shuter
Journal:  Am J Med       Date:  2018-01-31       Impact factor: 4.965

Review 6.  Considerations When Treating Hepatitis C in a Cirrhotic Transplant Candidate.

Authors:  Kimberly E Daniel; Adnan Said
Journal:  Curr Gastroenterol Rep       Date:  2018-04-05

7.  The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care.

Authors:  Andrew D Schreiner; John Bian; Jingwen Zhang; Z Merle Haulsee; Justin Marsden; Valerie Durkalski-Mauldin; Patrick D Mauldin; William P Moran; Don C Rockey
Journal:  Am J Med       Date:  2019-07-29       Impact factor: 4.965

8.  C-WORTHY: the beginning of the rise of elbasvir and grazoprevir for the treatment of hepatitis C genotype 1 mono and HIV co-infected patients.

Authors:  Dost Sarpel; Douglas T Dieterich
Journal:  Ann Transl Med       Date:  2016-10

9.  Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United States.

Authors:  Alexei Zelenev; Jianghong Li; Portia Shea; Robert Hecht; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

10.  Missed opportunities for prevention and treatment of hepatitis C among persons with HIV/HCV coinfection.

Authors:  Alexander J Millman; Qingwei Luo; Noele P Nelson; Claudia Vellozzi; John Weiser
Journal:  AIDS Care       Date:  2019-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.